Usana Health Sciences News

Usana Health Sciences Analyst Ratings

BenzingaMay 7 09:07 ET

Usana Health Sciences Analyst Ratings

BenzingaFeb 22 11:54 ET

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $53

BenzingaOct 25, 2023 12:16 ET

Usana Health Sciences Analyst Ratings

BenzingaOct 25, 2023 12:15 ET

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $56

BenzingaApr 26, 2023 10:12 ET

Usana Health Sciences Analyst Ratings

Benzinga Analyst RatingsFeb 13, 2023 10:03 ET

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $52.5

Benzinga Real-time NewsFeb 13, 2023 10:03 ET

DA Davidson Adjusts USANA Health Sciences' Price Target to $49 From $57, Keeps Neutral Rating

MT NewswiresOct 27, 2022 10:57 ET

Usana Health Sciences Analyst Ratings

Benzinga Analyst RatingsOct 27, 2022 04:53 ET

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $49

Benzinga Real-time NewsOct 27, 2022 04:51 ET

Usana Health Sciences analyst ratings

Benzinga Analyst RatingsJul 28, 2022 06:24 ET

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $57

Benzinga Real-time NewsJul 28, 2022 06:24 ET

USANA Health Sciences Is Maintained at Neutral by DA Davidson

Dow JonesJul 12, 2022 05:18 ET

USANA Health Sciences Price Target Cut to $58.00/Share From $76.00 by DA Davidson

Dow JonesJul 12, 2022 05:18 ET

Usana Health Sciences analyst ratings

Benzinga Analyst RatingsJul 12, 2022 05:08 ET

DA Davidson Lowers Price Target for USANA Health Sciences to $58 From $76, Maintains Neutral Rating

MT NewswiresJul 11, 2022 14:58 ET

USANA Health Sciences Price Target Cut to $53.00/Share From $78.00 by Jefferies

Dow JonesJul 7, 2022 12:17 ET

USANA Health Sciences Cut to Underperform From Hold by Jefferies

Dow JonesJul 7, 2022 12:17 ET

Usana Health Sciences analyst ratings

Benzinga Analyst RatingsJul 7, 2022 12:08 ET

Jefferies Downgrades Usana Health Sciences to Underperform, Lowers Price Target to $53

Benzinga Real-time NewsJul 7, 2022 12:08 ET